# Meridian Bioscience expands production capacity with NIH and JobsOhio support

Meridian Bioscience will increase production capacity of its SARS-CoV-2 molecular diagnostic test after receiving a $5.5M award from NIH and a grant from JobsOhio. The expansion includes a new facility in Newtown, Ohio, and will create 45 jobs, with maximum capacity of 800,000 tests per month by end of 2021.

- Type: Expansion
- Announced: 2021-02-03
- Where: Newtown, Ohio, United States
- Value: $7.00M
- Jobs: 45
- Starts operating: 2021
- Status: announced
- Capacity: 800,000 tests per month
- Products: SARS-CoV-2 molecular diagnostic test kits
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Meridian Bioscience](https://endata.com/companies/39174.md)

## Sources

- [meridianbioscience.com](https://www.meridianbioscience.com/press-release/meridian-bioscience-expands-production-capacity-with-support-from-nih-jobsohio-and-the-village-of-newtown/), 2021-02-03: "Our customers continue to search for more tests to battle this wave of the coronavirus pandemic and this support from our Federal, State and Local governments will be instrumental in scaling our manufacturing capacity."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.